Albio is to join Stago, global IVD Haemostasis leader

Back to list

The Stago Group, the world leader in Haemostasis and Thrombosis, has recently acquired Albio with the aim of developing its direct sales in Turkey.

Over the years, it has acquired a comprehensive understanding of the IVD business, from the design phase through to marketing and the on-site maintenance of systems and solutions at customers’ sites.

The company is continuing to develop its expertise thanks to not only its R&D and production sites in France, Germany, Ireland, the United States of America and China, but also its broad network of sales subsidiaries worldwide.

Stago has gained unanimous recognition among the international scientific community. It has built its reputation on its innovative strength and on always respecting customer needs, in research through to routine testing, in addition to providing high-quality services and customer satisfaction which are Stago’s founding values.